Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

December 27, 2021

Study Completion Date

November 26, 2022

Conditions
Vertigo
Interventions
DEVICE

Otoband

Participants with vertigo will wear the Otoband set at their chosen power level when experiencing symptoms.

DEVICE

Sham A

Sham Device A is an OtoBand in which the transducer is modified so that the vibrations are not targeted at the vestibular system.

DEVICE

Sham B

Sham Device B is an OtoBand that operates at power settings found to be nontherapeutic against vertigo associated with virtual reality.

Trial Locations (1)

20009

Otolith Labs, Washington D.C.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Otolith Labs

INDUSTRY

NCT04869020 - Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting | Biotech Hunter | Biotech Hunter